Home MarketAdinath Bio-Labs Ltd.

Adinath Bio-Labs Ltd. Stock Info: As on 2017-03-07 00:00:00

NO DATA AVAILABLE

Bse

0.30

-0.01(-3.23%)
Change %
52 Week Range
0.19
8.00
0.35
2.00
Open0.30
Day's Range0.29 - 0.33
Value Traded (in ₹ Cr.) 0.00

Stock Exchange

Category No. Of Shares Share %
ForeignPromoters 0.00 0.00%
IndianPromoters 56,838,005.00 25.75%
Mutual Funds/UTI 0.00 0.00%
FII 0.00 0.00%
Employee 0.00 0.00%
Public 100,597,848.00 45.57%
Government 0.00 0.00%
Others 63,306,707.00 28.68%
More

Key Statistics

Valuation Measures
Market Cap / Sales Ratio 5.21
Basic EPS (Rs.) 0.01
Cash EPS 0.01
BVPerShare Excl 1.33
Operating Revenue 0.03
PBDITPerShare 0.02
Dividend 0.00
NPPerShare 0.01
Current Ratio 3.96
Quick Ratio 3.96
PriceToBV 0.14
Earnings 0.03
PBDIT Margin 57.66
PBT Margin 37.70
NP Margin 17.84
Return On Assets 0.48
Retention Ratios 0.00
Parameter Mar-16 (₹ Cr.) Yoy%change
Total Income 1.00
Total Expenses 0.69
EBITDA 0.46
PBT 0.30
PAT 0.14
Net Income 0.14
More
Parameter Mar-16 (₹ Cr.) 6M % change
Total Income 0.37
Total Expenses 0.34
EBITDA -0.06
PBT 0.02
PAT 0.02
Net Income 0.00
More
Total Assets
Total Assets
Parameter Mar-16 (₹ Cr.) Yoy%change
Total share capital 22.07
Net worth 29.30
Investments 0.56
Total Liability 29.49
Total debt 0.00
Net block 2.42
Total Assets 29.49
Parameter Sep-16 (₹ Cr.) 6M % change
Total share capital 22.07
Net worth 29.44
Investments 0.56
Total Liability 29.59
Total debt 0.00
Net block 2.50
Total Assets 29.59
Company Curr Price Prev. Close Change% W's Low/High

Aarti Drugs Ltd.

648.8 655.8 -1.07
611680

Abbott India Ltd.

5518.15 5652.6 -2.38
5470.056159

Ajanta Pharma Ltd.

1391.75 1408 -1.15
13771446.95

Albert David Ltd.

384.15 390.6 -1.65
378410.85

Alembic Ltd.

61.05 62.35 -2.09
60.765

Alembic Pharmaceuticals Ltd.

576.45 577.15 -0.12
546.55589.4

Alkem Laboratories Ltd.

2164.4 2132.4 1.5
2115.12200.05
Company Curr Price Prev. Close Change% W's Low/High

Aarey Drugs & Pharmaceuticals Ltd.

51.7 53.9 -4.08
50.7557.55

Aarti Drugs Ltd.

650 656 -0.91
614680

Aayush Food & Herbs Ltd.

62.65 66.05 -5.15
61.680.35

Abbott India Ltd.

5675 5633.45 0.74
55006109.95

ABL Bio-Technologies Ltd.

0.81 0.78 3.85
0.750.81

Addlife Pharma Ltd.

0.46 0 0
0.460.5

Advik Laboratories Ltd.

5.61 5.9 -4.92
5.496.05
More
Parameter Mar-16(in ₹ Cr.)
Cash from operating activities -2.60
Cash from investing activities 2.58
Cash from financing activities 0.00
Net change in cash -0.02

Stock Held By Mutual Fund Schemes

KDDL Q3 net profit zooms 200.71% at Rs 4.21 cr

The company reported standalone net profit of Rs 4.21 crore for the quarter ended December 31, 2017 as compared to Rs 1.40 crore in the same period last year, registering a year-on-year growth of 200.71 per cent. Net revenue of the company rose substantially by 25.44 per cent at Rs 35.35 crore in October-December quarter of this fiscal as against Rs 28.18 crore in the corresponding period last year. During October-December quarter, operating expenses increased by 17.68 per cent to Rs 28.62 crore from Rs 24.32 crore in year ago period. Other Income grew by 818.18 per cent at Rs 2.02 crore versus (Dec'16 Rs 0.22 crore). Operating Profit surged by 31.19 per cent to Rs 6.73 crore as against Rs 5.13 crore in the year ago period, while Operating Profit Margin (OPM) expanded year-on-year to 4.62 per cent in December quarter. Interest declined by 17.24 per cent y-o-y to Rs 1.20 crore, while Taxation increased by 94.67 per cent at Rs 1.46 crore (Dec'16 Rs 0.75 crore).

16-02-2018 18:52

DIC India posts Q4 net loss of Rs 3.51 cr

The company reported standalone net loss during the quarter stood at Rs 3.51 crore compared to net profit of Rs 5.12 crore in the previous year quarter. Net revenue of the company rose moderately by 11.52 per cent at Rs 199.54 crore in October-December quarter of this fiscal as against Rs 178.93 crore in the corresponding period last year. During October-December quarter, operating expenses increased by 11.47 per cent to Rs 195.08 crore from Rs 175.01 crore in year ago period. Other Income dipped by 48.77 per cent at Rs 1.87 crore versus (Dec'16 Rs 3.65 crore). Operating Profit slipped by 8.23 per cent to Rs 4.46 crore as against Rs 4.86 crore in the year ago period, while Operating Profit Margin (OPM) contracted year-on-year to 17.34 per cent in December quarter. Interest declined by 13.48 per cent y-o-y to Rs 0.77 crore, while Taxation increased by 418.66 per cent at Rs -6.95 crore (Dec'16 Rs -1.34 crore).

16-02-2018 18:52

Varun Beverages posts Q4 net loss of Rs 69.08 cr

The company reported standalone net loss during the quarter stood at Rs 69.08 crore as compared to net loss of Rs 68.84 crore in the previous year quarter. Net revenue of the company rose substantially by 36.65 per cent at Rs 329.92 crore in October-December quarter of this fiscal as against Rs 241.44 crore in the corresponding period last year. During October-December quarter, operating expenses increased by 23.91 per cent to Rs 322.91 crore from Rs 260.60 crore in year ago period. Other Income dipped by 99.09 per cent at Rs 0.27 crore versus (Dec'16 Rs 29.59 crore). Operating Profit surged by 154.22 per cent to Rs 7.01 crore as against Rs -12.93 crore in the year ago period, while Operating Profit Margin (OPM) contracted year-on-year to 139.81 per cent in December quarter. Interest grew by 40.03 per cent y-o-y to Rs 53.14 crore, while Taxation increased by 54.77 per cent at Rs -46.54 crore (Dec'16 Rs -30.07 crore).

16-02-2018 18:52

Jayshree Tea Q3 net profit zooms 8589.47% at Rs 16.51 cr

The company reported standalone net profit of Rs 16.51 crore for the quarter ended December 31, 2017 as compared to Rs 0.19 crore in the same period last year, registering a year-on-year growth of 8589.47 per cent. Net revenue of the company rose moderately by 20.00 per cent at Rs 202.33 crore in October-December quarter of this fiscal as against Rs 168.61 crore in the corresponding period last year. During October-December quarter, operating expenses increased by 11.77 per cent to Rs 178.94 crore from Rs 160.10 crore in year ago period. Other Income grew by 39.32 per cent at Rs 5.74 crore versus (Dec'16 Rs 4.12 crore). Operating Profit surged by 142.13 per cent to Rs 23.39 crore as against Rs 9.66 crore in the year ago period, while Operating Profit Margin (OPM) expanded year-on-year to 101.75 per cent in December quarter. Interest declined by 12.02 per cent y-o-y to Rs 8.86 crore

16-02-2018 18:52

Rights: Indiabulls Ventures to issue 3 shares for every 16 held

Indiabulls Ventures, one of India's leading capital market companies, on Friday said that it will raise upto Rs 2,000 crore on a rights basis to the eligible equity shareholders of the company in the ratio of 3 rights equity shares for every 16 fully paid-up equity shares. “The company to issue upto 83,333,333 partly paid up equity shares of face value of Rs 2 each of Indiabulls Ventures for cash at a price of Rs 240 (including a premium of Rs 238) per equity share for an amount aggregating up to Rs 20,000 million on a rights basis to the eligible equity shareholders of the company in the ratio of 3 rights equity shares for every 16 fully paid-up equity shares held by such eligible equity shareholders on the Record Date, i.e. on February 12, 2018,” the company said in a filing to the Bombay Stock Exchange. Meanwhile, shares of company closed day’s trade at Rs 253.20 apiece, up 1.32 per cent, on the Bombay Stock Exchange on Friday.

16-02-2018 17:01

Corporate Details

About Management

2008

- The Company has splits its face value from Rs10/- to Rs1/-.

2009

--Registered Office of the Company has been shifted form "Suite No.18, 2 India Exchange Place, Kolkata - 700001" to "4, N.S.Road, 1st Floor, Kolkata - 700001."

Registered Office

4, N. S. Road, 1st Floor

033-22315718,,,      033-22315718,

investors@adinathbio.com

http://www.adinathbio.com

Registrar Details

Adroit Corporate Service (P) Ltd.